Apellis Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGS:APLS Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
19 Mar 24	SellUS$1,068,161	Epidarex Capital	Company	18,681	US$57.18
18 Mar 24	SellUS$564,050	Mark Delong	Individual	9,913	US$56.90
15 Mar 24	SellUS$10,389	James Chopas	Individual	184	US$56.46
13 Mar 24	SellUS$645,838	Nur Nicholson	Individual	11,220	US$58.13
12 Feb 24	SellUS$40,457	Mark Delong	Individual	597	US$67.77
12 Feb 24	SellUS$96,974	Timothy Sullivan	Individual	1,431	US$67.77
12 Feb 24	SellUS$77,796	Adam Townsend	Individual	1,148	US$67.77
12 Feb 24	SellUS$52,926	David Watson	Individual	781	US$67.77
12 Feb 24	SellUS$268,492	Cedric Francois	Individual	3,962	US$67.77
12 Feb 24	SellUS$77,796	Pascal Deschatelets	Individual	1,148	US$67.77
29 Jan 24	SellUS$23,539	Mark Delong	Individual	367	US$64.14
29 Jan 24	SellUS$17,895	Jeffrey Eisele	Individual	279	US$64.14
29 Jan 24	SellUS$182,345	Cedric Francois	Individual	2,843	US$64.14
29 Jan 24	SellUS$56,057	Pascal Deschatelets	Individual	874	US$64.14
29 Jan 24	SellUS$58,109	Adam Townsend	Individual	906	US$64.14
29 Jan 24	SellUS$58,109	David Watson	Individual	906	US$64.14
29 Jan 24	SellUS$53,555	Nur Nicholson	Individual	835	US$64.14
29 Jan 24	SellUS$58,109	Timothy Sullivan	Individual	906	US$64.14
29 Jan 24	SellUS$23,539	Karen Lewis	Individual	367	US$64.14
22 Jan 24	SellUS$254,329	Pascal Deschatelets	Individual	3,913	US$65.00
22 Jan 24	SellUS$221,831	Adam Townsend	Individual	3,413	US$65.00
22 Jan 24	SellUS$271,943	David Watson	Individual	4,184	US$65.00
22 Jan 24	SellUS$112,963	Karen Lewis	Individual	1,738	US$65.00
22 Jan 24	SellUS$168,535	Nur Nicholson	Individual	2,593	US$65.00
22 Jan 24	SellUS$230,801	Timothy Sullivan	Individual	3,551	US$65.00
22 Jan 24	SellUS$89,954	Mark Delong	Individual	1,384	US$65.00
22 Jan 24	SellUS$68,961	James Chopas	Individual	1,061	US$65.00
22 Jan 24	SellUS$104,449	Jeffrey Eisele	Individual	1,607	US$65.00
22 Jan 24	SellUS$872,961	Cedric Francois	Individual	13,431	US$65.00
16 Jan 24	SellUS$524,514	Cedric Francois	Individual	7,851	US$66.81
16 Jan 24	SellUS$109,032	Karen Lewis	Individual	1,632	US$66.81
16 Jan 24	SellUS$149,317	Timothy Sullivan	Individual	2,235	US$66.81
16 Jan 24	SellUS$124,064	Nur Nicholson	Individual	1,857	US$66.81
16 Jan 24	SellUS$109,032	Pascal Deschatelets	Individual	1,632	US$66.81
16 Jan 24	SellUS$149,317	Adam Townsend	Individual	2,235	US$66.81
16 Jan 24	SellUS$283,268	David Watson	Individual	4,240	US$66.81
16 Jan 24	SellUS$29,262	Jeffrey Eisele	Individual	438	US$66.81
16 Jan 24	SellUS$108,965	Mark Delong	Individual	1,631	US$66.81
16 Jan 24	SellUS$57,723	James Chopas	Individual	864	US$66.81
04 Jan 24	SellUS$165,207	Caroline Baumal	Individual	2,751	US$60.05
26 Dec 23	SellUS$3,935	Jeffrey Eisele	Individual	68	US$57.86
01 Dec 23	SellUS$1,467,240	Epidarex Capital	Company	24,000	US$61.14
21 Nov 23	SellUS$244,000	Cedric Francois	Individual	5,000	US$48.80
17 Nov 23	SellUS$444,620	A. Dunlop	Individual	8,894	US$49.99
23 Oct 23	SellUS$6,031	Mark Delong	Individual	131	US$46.04
23 Oct 23	SellUS$6,077	James Chopas	Individual	132	US$46.04
17 Oct 23	SellUS$1,176,000	Epidarex Capital	Company	24,000	US$49.00
18 Sep 23	SellUS$490,589	Nur Nicholson	Individual	10,631	US$46.15
06 Sep 23	SellUS$75,526	Lukas Scheibler	Individual	1,756	US$43.01
31 Aug 23	SellUS$22,716	James Chopas	Individual	551	US$41.23

Insider Trading Volume

Insider Buying: APLS insiders have only sold shares in the past 3 months.

Ownership Breakdown

What is the ownership structure of APLS?
Owner Type	Number of Shares	Ownership Percentage
Private Companies	827	0.000625%
State or Government	45,130	0.0341%
Individual Insiders	4,320,354	3.27%
VC/PE Firms	12,806,342	9.69%
Hedge Funds	22,468,536	17%
Institutions	92,581,256	70%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 4.2%.

Top Shareholders

Top 25 shareholders own 85.73% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
12.4%	Wellington Management Group LLP	15,058,071	US$632.4m	-8.44%	0.1%
10.6%	The Morningside Group Limited	12,806,342	US$537.9m	0%	85.4%
9.36%	EcoR1 Capital, LLC	11,357,425	US$477.0m	1.65%	13.85%
9.16%	Avoro Capital Advisors LLC	11,111,111	US$466.7m	0%	5.62%
7.83%	The Vanguard Group, Inc.	9,505,866	US$399.2m	-0.52%	0.01%
5.82%	T. Rowe Price Group, Inc.	7,064,967	US$296.7m	-19.4%	0.03%
4.53%	BlackRock, Inc.	5,494,591	US$230.8m	2.11%	no data
2.67%	Jennison Associates LLC	3,240,513	US$136.1m	-1.08%	0.08%
2.4%	State Street Global Advisors, Inc.	2,909,528	US$122.2m	-0.2%	no data
2.31%	Octagon Capital Advisors LP	2,806,980	US$117.9m	0%	15.96%
1.8%	FMR LLC	2,178,673	US$91.5m	4.12%	0.01%
1.76%	JP Morgan Asset Management	2,131,400	US$89.5m	-8.44%	0.01%
1.67%	Assenagon Asset Management S.A.	2,023,614	US$85.0m	-5.66%	0.18%
1.51%	Cedric Francois	1,834,224	US$77.0m	-2.11%	no data
1.42%	Tavistock Life Sciences	1,726,000	US$72.5m	0%	3.76%
1.39%	Geode Capital Management, LLC	1,689,890	US$71.0m	3.63%	0.01%
1.31%	Deutsche Asset & Wealth Management	1,593,606	US$66.9m	106%	0.03%
1.24%	Morgan Stanley, Investment Banking and Brokerage Investments	1,501,990	US$63.1m	-49%	0.01%
1.08%	Artal Group S.A.	1,315,282	US$55.2m	-7.46%	1.3%
1.07%	OrbiMed Advisors LLC	1,297,800	US$54.5m	40.7%	0.73%
0.98%	Citadel Advisors LLC	1,186,082	US$49.8m	316%	0.05%
0.9%	Pascal Deschatelets	1,089,397	US$45.8m	0.23%	no data
0.88%	Pictet Asset Management Limited	1,073,234	US$45.1m	-20.2%	0.03%
0.87%	Polar Capital Holdings Plc	1,054,440	US$44.3m	0.09%	0.18%
0.82%	Deep Track Capital, LP	1,000,000	US$42.0m	0%	1.27%